Thursday, 20 December 2018

AstraZeneca's ovarian cancer and anemia treatments meet goals in late-stage studies

British drugmaker AstraZeneca on Thursday said its ovarian cancer and anemia treatments met their goals in three separate late stage trials.


from Reuters: Health News https://ift.tt/2Lslx1z

No comments:

Post a Comment